Related Experiment Video

Updated: May 8, 2026

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)

Published on: March 7, 2017

A new era for children with diffuse intrinsic pontine glioma: hope for cure?

Marc H A Jansen, Gertjan J Kaspers

    Expert Review of Anticancer Therapy
    |October 27, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
    07:39

    Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions

    Published on: November 17, 2021

    Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
    09:06

    Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

    Published on: November 11, 2021

    Related Experiment Videos

    Last Updated: May 8, 2026

    A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)
    08:46

    A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)

    Published on: March 7, 2017

    Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
    07:39

    Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions

    Published on: November 17, 2021

    Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
    09:06

    Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

    Published on: November 11, 2021

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

    Articles linked to this work by shared authors, journal, and citation graph.

    Digital home monitoring in patients with juvenile idiopathic arthritis to increase intervals of hospital visits.

    Rheumatology (Oxford, England)·2026

    Persistent hypogammaglobulinemia after rituximab therapy in pediatric patients, prevalence and clinical outcomes.

    Clinical immunology communications·2026

    Adoption of new treatment options in non-systemic juvenile idiopathic arthritis (JIA) in clinical practice.

    Pediatric rheumatology online journal·2025

    Population Pharmacokinetics of Total and Protein-Unbound Prednisolone in Children with Immune-Mediated and Systemic Inflammatory Diseases.

    Clinical pharmacokinetics·2025

    Advances in JDM: biomarker and MRI sensitivity, outcomes and steroid management in a Dutch national prospective cohort.

    Rheumatology (Oxford, England)·2025

    Impact of Interleukin-1 Blockade on the Development of Macrophage Activation Syndrome in Still Disease: Incidence and Diagnostic Validity of the EULAR/ACR/PRINTO 2016 MAS Classification Criteria.

    Arthritis & rheumatology (Hoboken, N.J.)·2025

    Prospective patient preference study for chronic lymphocytic leukemia (CLL) treatment attributes impacting patient shared decision-making.

    Expert review of anticancer therapy·2026

    Adjuvant therapy for resectable gastrointestinal stromal tumors: evidence, controversies, and practical guidance.

    Expert review of anticancer therapy·2026

    Real-world outcomes of ribociclib treatment in HR-positive/HER2-negative metastatic breast cancer: efficacy, safety, and prognostic factors.

    Expert review of anticancer therapy·2026

    Salivary duct carcinoma- contemporary nuts and bolts from pathologist perspective.

    Expert review of anticancer therapy·2026

    Machine learning integrated explainable artificial intelligence in predicting toxicities of enfortumab vedotin in urothelial carcinoma: an exploratory study.

    Expert review of anticancer therapy·2026

    Overcoming emerging challenges in childhood cancer survivorship: a spotlight on pediatric CNS tumors.

    Expert review of anticancer therapy·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us